Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2017

Open Access 01-12-2017 | Case report

Treatment of pruritus in a palliative care patient with low-dose paroxetine: a case report

Author: Roni Y. Kraut

Published in: Journal of Medical Case Reports | Issue 1/2017

Login to get access

Abstract

Background

Pruritus is a distressing symptom seen in palliative care. There is limited high-quality evidence of pharmaceutical treatments for pruritus in palliative care, including the use of paroxetine.

Case presentation

I present a case of a 70-year-old caucasian woman with metastatic ovarian cancer who presented with severe pruritus. She had been diagnosed with bile duct obstruction 1 month earlier. Antihistamines and over-the-counter skin creams were first trialed, to no effect. Paroxetine was started at 5 mg in the evening, with the intention of titrating up. However, 5 mg of paroxetine was effective, and the patient’s pruritus fully resolved after the second day.

Conclusions

This case supports the use of paroxetine as a therapy for pruritus in palliative care patients and suggests that paroxetine may be effective at a very low dose.
Literature
1.
go back to reference Siemens W, Xander C, Meerpohl JJ, Buroh S, Antes G, Schwarzer G, Becker G. Pharmacological interventions for pruritus in adult palliative patients. Cochrane Database Syst Rev. 2016;11:CD008320.PubMed Siemens W, Xander C, Meerpohl JJ, Buroh S, Antes G, Schwarzer G, Becker G. Pharmacological interventions for pruritus in adult palliative patients. Cochrane Database Syst Rev. 2016;11:CD008320.PubMed
2.
go back to reference Weisshaar E, Kucenic MJ, Fleischer Jr AB. Pruritus: a review. Acta Derm Venereol Suppl. 2003;213:5–32. Weisshaar E, Kucenic MJ, Fleischer Jr AB. Pruritus: a review. Acta Derm Venereol Suppl. 2003;213:5–32.
4.
go back to reference Drugs for pruritus. In: Twycross R, Wilcock A, Howard P, editors. Palliative care formulary. Nottingham, UK: palliativedrugs.com; 2016. p. 940–8. Drugs for pruritus. In: Twycross R, Wilcock A, Howard P, editors. Palliative care formulary. Nottingham, UK: palliativedrugs.com; 2016. p. 940–8.
5.
go back to reference Alshammary SA, Duraisamy BP, Alsuhail A. Review of management of pruritus in palliative care. J Health Spec. 2016;4:17–23.CrossRef Alshammary SA, Duraisamy BP, Alsuhail A. Review of management of pruritus in palliative care. J Health Spec. 2016;4:17–23.CrossRef
6.
go back to reference CPS [internet]. Ottawa (ON): Canadian Pharmacists Association. Paroxetine [product monograph]. Available from http://www.e-cps.ca. c2016 [updated 4 Jan 2016; cited 15 June 2017]. CPS [internet]. Ottawa (ON): Canadian Pharmacists Association. Paroxetine [product monograph]. Available from http://​www.​e-cps.​ca. c2016 [updated 4 Jan 2016; cited 15 June 2017].
7.
go back to reference Zylicz Z, Smits C, Krajnik M. Paroxetine for pruritus in advanced cancer. J Pain Symptom Manage. 1998;16:121–4.CrossRefPubMed Zylicz Z, Smits C, Krajnik M. Paroxetine for pruritus in advanced cancer. J Pain Symptom Manage. 1998;16:121–4.CrossRefPubMed
8.
go back to reference Tefferi A, Fonseca R. Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus. Blood. 2002;99:2627.CrossRefPubMed Tefferi A, Fonseca R. Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus. Blood. 2002;99:2627.CrossRefPubMed
9.
go back to reference Diehn F, Terreri A. Pruritus in polycythaemia vera: prevalence, laboratory correlates and management. Br J Haematol. 2001;115:619–21.CrossRefPubMed Diehn F, Terreri A. Pruritus in polycythaemia vera: prevalence, laboratory correlates and management. Br J Haematol. 2001;115:619–21.CrossRefPubMed
10.
go back to reference Kümler T, Hedlund D, Hast R, Hasselbalch HC. Aquagenic pruritus from polycythaemia vera – treatment with paroxetine, a selective serotonin reuptake inhibitor [in Danish]. Ugeskr Laeger. 2008;170:2981.PubMed Kümler T, Hedlund D, Hast R, Hasselbalch HC. Aquagenic pruritus from polycythaemia vera – treatment with paroxetine, a selective serotonin reuptake inhibitor [in Danish]. Ugeskr Laeger. 2008;170:2981.PubMed
11.
go back to reference Weisshaar E. Intractable chronic pruritus in a 67-year-old man. Acta Derm Venereol. 2008;88:488–90.CrossRefPubMed Weisshaar E. Intractable chronic pruritus in a 67-year-old man. Acta Derm Venereol. 2008;88:488–90.CrossRefPubMed
12.
go back to reference Unotoro J, Nonaka E, Takita N, Suzuki Y. Paroxetine treatment of 3 cases of cholestatic pruritus due to gastrointestinal malignancy. Nihon Shokakibyo Gakkai Zasshi. 2010;107:257–62.PubMed Unotoro J, Nonaka E, Takita N, Suzuki Y. Paroxetine treatment of 3 cases of cholestatic pruritus due to gastrointestinal malignancy. Nihon Shokakibyo Gakkai Zasshi. 2010;107:257–62.PubMed
13.
go back to reference Zylicz Z, Krajnik M, van Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage. 2003;26:1105–12.CrossRefPubMed Zylicz Z, Krajnik M, van Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage. 2003;26:1105–12.CrossRefPubMed
Metadata
Title
Treatment of pruritus in a palliative care patient with low-dose paroxetine: a case report
Author
Roni Y. Kraut
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2017
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-017-1437-6

Other articles of this Issue 1/2017

Journal of Medical Case Reports 1/2017 Go to the issue